Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Aclarion's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.09M. For fiscal 2025 it was -$7.16M. The highest annual figure on record is -$2.40M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.16M | – |
| FY2024 | Dec 31, 2024 | -$5.27M | – |
| FY2023 | Dec 31, 2023 | -$3.65M | – |
| FY2022 | Dec 31, 2022 | -$4.95M | – |
| FY2021 | Dec 31, 2021 | -$2.40M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.16M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.51M | – |
| Q4 FY2024 | Dec 31, 2024 | -$922.86K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.05M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$733.78K | – |
| Q3 FY2023 | Sep 30, 2023 | -$952.51K | – |
| Q2 FY2023 | Jun 30, 2023 | -$947.54K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.14M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$832.26K | – |
| Q3 FY2021 | Sep 30, 2021 | -$829.02K | – |
| Q2 FY2021 | Jun 30, 2021 | -$492.20K | – |
| Q1 FY2021 | Mar 31, 2021 | -$246.47K | – |